Article Versions Notes

Iyer N, Williams MA, O’Callaghan AA, Dempsey E, Cabrera-Rubio R, Raverdeau M, Crispie F, Cotter PD, Corr SC. Lactobacillus salivarius UCC118™ Dampens Inflammation and Promotes Microbiota Recovery to Provide Therapeutic Benefit in a DSS-Induced Colitis Model. Microorganisms. 2022; 10(7):1383. https://doi.org/10.3390/microorganisms10071383

Iyer, Namrata, Michelle A. Williams, Amy A. O’Callaghan, Elaine Dempsey, Raul Cabrera-Rubio, Mathilde Raverdeau, Fiona Crispie, Paul D. Cotter, and Sinéad C. Corr. 2022. "Lactobacillus salivarius UCC118™ Dampens Inflammation and Promotes Microbiota Recovery to Provide Therapeutic Benefit in a DSS-Induced Colitis Model" Microorganisms 10, no. 7: 1383. https://doi.org/10.3390/microorganisms10071383

Iyer, N., Williams, M. A., O’Callaghan, A. A., Dempsey, E., Cabrera-Rubio, R., Raverdeau, M., Crispie, F., Cotter, P. D., & Corr, S. C. (2022). Lactobacillus salivarius UCC118™ Dampens Inflammation and Promotes Microbiota Recovery to Provide Therapeutic Benefit in a DSS-Induced Colitis Model. Microorganisms, 10(7), 1383. https://doi.org/10.3390/microorganisms10071383